BK Virus Nephropathy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which BK Virus Nephropathy trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT05325008

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

BEAT-BK will see the effect of immunosuppression reduction/modification with and without IVIG on BKPyV infection, allograft function, allograft loss, acute tran…

Australia280 participantsStarted 2023-08-18

Treatment: Immunosuppression reduction/modification + intravenous immunoglobulin, Immunosuppression reduction/modification

All recent trials (28 shown)

WithdrawnNot Applicable

NCT04984902

Reduction of BK Viremia in Kidney Transplant Patients

Reduction of BK Viremia by treating kidney transplant patients.

Germany0Started 2022-02-01

Treatment: Extracorporal therapy

Not Yet RecruitingNot Applicable

NCT07393594

ID-ENTITY Trial- Evaluating Serial T-ID Monitoring

To evaluate the association between time-updated CMV and BK viral loads measured monthly by T-ID and the risk of CMV disease and/or biopsy-proven BK virus-assoc…

Location not specified1,000 participantsStarted 2026-03-31

Treatment: Blood tests, TRAC( cell free DNA) and T-ID

BK Virus Nephropathy

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

All recent trials (28 shown)

Reduction of BK Viremia in Kidney Transplant Patients

ID-ENTITY Trial- Evaluating Serial T-ID Monitoring

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

All recent trials (28 shown)

Reduction of BK Viremia in Kidney Transplant Patients

ID-ENTITY Trial- Evaluating Serial T-ID Monitoring

Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals…

Prediction of BK Virus Reactivation in Kidney Transplant Recipient

VIRTUUS Children's Study

Salivary Replication of BK Virus in Post-kidney Transplant

Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.

Study of Anti-BKPyV Immune Responses in Kidney Transplant Patients With BKPyV Viremia

Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kid…

Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia

Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia

Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers.

Haufen Diagnostic Biomarkers of BK Renal Disease

Evaluation of a Predictive Immunovirological Test Occurrence of BK Virus Nephropathy in Renal Transplant

Evaluation of Renal Pretransplant Serology for BK Virus on the Risk of Post-transplant Viral Reactivation

An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients

BK Virus Post-Kidney Transplant: New Practice Versus Traditional Approach

Study of the Pathogenicity and Humoral Immune Response Induced by BK Virus in Lung Transplant Recipients

Ciprofloxacin for Prevention of BK Infection

Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant…